Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.60 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.60 |
| ▸ | GSK3B | P49841 | 7/20 | 0.58 |
| ▸ | GSK3A | P49840 | 6/20 | 0.58 |
| ▸ | AURKA | O14965 | 3/20 | 0.58 |
| ▸ | PLK1 | P53350 | 3/20 | 0.52 |
| ▸ | PTK2 | Q05397 | 4/20 | 0.50 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.48 |
| ▸ | SYK | P43405 | 1/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5422179 | 0.89 | GSK3B (0.68) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5408106 | 0.86 | MAPT (0.54) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5417264 | 0.86 | GSK3B (0.59) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| Hydrochloric Acid SCHEMBL5408749 | 0.84 | GSK3B (0.56) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5402268 | 0.83 | GSK3B (0.82) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5416170 | 0.83 | STK17A (0.57) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5413809 | 0.83 | GSK3B (0.56) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5422211 | 0.82 | MEN1 (0.67) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5408359 | 0.82 | MAPT (0.86) | MEN1CYP1A2CYP3A4MAPTCYP2C9 | |
| SCHEMBL5416097 | 0.82 | GSK3B (0.54) | MEN1CYP1A2CYP3A4MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166599-B2 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-20050090486-A1 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-04-28 | — | — | US | disclosed |
| US-20030134838-A1 | Trisubstituted pyrimidines | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030134838-A1 | Trisubstituted pyrimidines | APP, PSEN1, BACE1 | MEN1 3119/4885CYP1A2 409/4885CYP3A4 733/4885 |
| US-20050090486-A1 | Trisubstituted pyrimidines | APP, BACE1, PSEN1 | MEN1 2729/4885CYP1A2 290/4885CYP3A4 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.